Purple Biotech

Purple BiotechPurple Biotech
Purple Biotech

Purple Biotech

Clinical-stage company developing novel oncology therapies to overcome tumor immune evasion and drug resistance.

DR 272013Active19Tel Aviv, Israel
Rate

About

Purple Biotech Ltd. is a clinical-stage biopharmaceutical company focused on developing first-in-class therapies designed to address tumor immune evasion and drug resistance. Their pipeline includes promising drug candidates such as NT219, CM24, and IM1240, aiming to provide new treatment options for cancer patients.
Frequently asked

What does Purple Biotech do?

Purple Biotech Ltd. is a clinical-stage biopharmaceutical company focused on developing first-in-class therapies designed to address tumor immune evasion and drug resistance. Their pipeline includes promising drug candidates such as NT219, CM24, and IM1240, aiming to provide new treatment options for cancer patients. (formerly Kitov Pharma.)

What is Purple Biotech's revenue?

StartupHub estimates Purple Biotech's annual revenue at $3.9M (range $2.3M to $9.5M, 65% confidence), based on comparable companies in the sector.

Where is Purple Biotech headquartered?

Purple Biotech is headquartered in Tel Aviv, Israel.

When was Purple Biotech founded?

Purple Biotech was founded in 2013.

What industry does Purple Biotech operate in?

Purple Biotech operates in Biotech, Life Sciences, Drug Discovery, Clinical Trials, Oncology, Therapeutics.

How many employees does Purple Biotech have?

Purple Biotech has approximately 19 people on record.

HEADCOUNT
19
DOMAIN RATING
27
Comments
(6)
4 positive2 mixed0 negative
Reddit
r/biotech_stocksu/Albertogn12Jun 11, 2026Positive💎

Purple Biotech presenta nuevos datos preclínicos en EACR 2026 que destacan la actividad antitumoral de IM1240, su favorable perfil de seguridad y farmacocinético, y su amplio margen terapéutico.

View on Reddit
Reddit
r/Quantisnowu/QuantisnowJun 11, 2026Positive

Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window.

View on Reddit
Reddit
r/Quantisnowu/QuantisnowMay 15, 2026Mixed

Purple Biotech Reports First Quarter 2026 Financial Results and Business Highlights.

View on Reddit
Reddit
r/Quantisnowu/QuantisnowApr 27, 2026Positive

Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240.

View on Reddit
Reddit
r/StockTitanu/Stock_TitanApr 27, 2026Positive

PPBT | Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240.

View on Reddit
Reddit
r/redditu/MarketNewsFlowDec 6, 2025Mixed

Purple Biotech (NASDAQ: $PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. Created by WallStreetWire which Purple Biotech is a paid subscriber of: wallstwir…

View on Reddit

Some comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.